171 related articles for article (PubMed ID: 2640698)
1. [Adipose tissue distribution in children with excessive body weight and the possibility of development of complications of obesity. II. Positive family history in relation to arteriosclerosis risk factor and the constitutional type of obesity in children].
Krawczuk-Rybakowa M; Pedziński W; Urban M; Siwiński J
Pediatr Pol; 1989 Jul; 64(7):467-73. PubMed ID: 2640698
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between body mass index, lipoprotein (a) level and positive family history of cardiovascular diseases in children and adolescents with obesity, hypertension and diabetes].
Głowińska B; Urban M; Koput A
Pol Merkur Lekarski; 2002 Feb; 12(68):108-14. PubMed ID: 11995245
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation and prevention of type II diabetes mellitus and cardiovascular diseases in obese children and adolescents: a public health intervention in a local health organisation in Rome (Italy)].
Doro Altan AM; Manca Bitti ML; Buonomo E; Scarcella P; Mancinelli S; Arcano S; Palombi L
Ig Sanita Pubbl; 2008; 64(3):345-60. PubMed ID: 18936798
[TBL] [Abstract][Full Text] [Related]
4. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
Van Gaal L
Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
[TBL] [Abstract][Full Text] [Related]
5. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
Song SH; Hardisty CA
QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
[TBL] [Abstract][Full Text] [Related]
6. [Obesity related complications in children and adolescents].
Fichna P; Skowrońska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):223-8. PubMed ID: 17020660
[TBL] [Abstract][Full Text] [Related]
7. Atherogenic risk in obese and in diabetic children.
Popa I; Drăgan M; Georgescu L; Deutsch G; Oţetea G; Schmidt-Georoceanu A; Man I; Grigoriţa M; Beligan C; Popa Z
Endocrinologie; 1984; 22(1):61-70. PubMed ID: 6369504
[TBL] [Abstract][Full Text] [Related]
8. Obesity and other risk factors in children.
Falkner B; Michel S
Ethn Dis; 1999; 9(2):284-9. PubMed ID: 10421092
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y polymorphism significantly magnifies diabetes and cardiovascular disease risk in obesity: the Hoorn Study.
Jaakkola U; Kallio J; Heine RJ; Nijpels G; T' Hart LM; Maassen JA; Bouter LM; Stehouwer CD; Dekker JM
Eur J Clin Nutr; 2009 Jan; 63(1):150-2. PubMed ID: 18043699
[TBL] [Abstract][Full Text] [Related]
10. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
Haffner SM
Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease in genotypes for obesity and diabetes.
McCune SA
Nutrition; 1989; 5(1):52-5. PubMed ID: 2520259
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing the epidemiology of and interrelations between atherosclerosis and diabetes mellitus.
Pfeiffer EF
Acta Diabetol Lat; 1971 Sep; 8 Suppl 1():425-8. PubMed ID: 5146915
[No Abstract] [Full Text] [Related]
13. [Profile of the main risk factors of arteriosclerosis in patients with diabetes mellitus].
Tatoń J; Walewski J
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):3-7. PubMed ID: 1409038
[No Abstract] [Full Text] [Related]
14. [Predictive examinations of phenotypically healthy offspring of patients with a metabolic syndrome].
Kopf D; Lehnert H
Dtsch Med Wochenschr; 2001 Mar; 126(9):235-40. PubMed ID: 11256038
[No Abstract] [Full Text] [Related]
15. [Effect of body mass reduction in obese patients with abnormal glucose tolerance and diabetes on selected arteriosclerosis risk factors].
Graczykowska-Koczorowska A; Ponikowska I; Zietek J; Dubowska-Kolasa E; Walkowiak M
Pol Tyg Lek; 1982 Jun; 37(19-20):559-63. PubMed ID: 7177947
[No Abstract] [Full Text] [Related]
16. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study.
Kelishadi R; Cook SR; Motlagh ME; Gouya MM; Ardalan G; Motaghian M; Majdzadeh R; Ramezani MA
J Am Diet Assoc; 2008 Jan; 108(1):82-90. PubMed ID: 18155992
[TBL] [Abstract][Full Text] [Related]
17. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease.
Després JP
J Endocrinol Invest; 2006; 29(3 Suppl):77-82. PubMed ID: 16751711
[TBL] [Abstract][Full Text] [Related]
18. [Paraclinical and clinical correlations on the implications of obesity in the pathogenesis of diabetes mellitus and atherosclerosis].
Creţeanu G; Jalobceastâi D; Cepoi V; Beşchea M; Ursuleanu G; Stanciu R; Pleşcan C; Creţeanu M; Creţeanu G; Munteanu G
Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):307-12. PubMed ID: 4089333
[No Abstract] [Full Text] [Related]
19. Cardiovascular risk factors in obese women and their first-degree relatives.
Saraç F; Ozgen AG; Yilmaz C; Tüzün M
Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
[TBL] [Abstract][Full Text] [Related]
20. [Obesity, diabetes, cancer and cardiovascular risk: a trans-generational network].
Guiducci L; Pasanisi E; Capati E; Iozzo P
Recenti Prog Med; 2010 Apr; 101(4):170-4. PubMed ID: 20540403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
